Application

18166996 · TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND DIABETIC MACULAR EDEMA BY ADMINISTRATION OF A BISPECIFIC ANTIBODY TO VEGF AND ANG-2

Filed 2023-02-09 · Granted · Patent 12624098 (2026-05-12) The official file ↗The patent and its PDF ↗ · Art unit 1645 · Examiner Christine J Saoud Typical · CPC A61K 39/00 · Genentech, Inc. · GENENTECH, INC.

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

8.8 mo

to disposition 39.0 mo

Statutes raised

102 103 112

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.